
|Articles|August 25, 2017
New Specialty Drug Indications of 2017
Author(s)Lauren Santye, Assistant Editor
Treatments for hepatitis C, hemophilia, and cholesterol among specialty drugs approved for new indications this year.
Advertisement
The process of bringing a drug to market is expensive and can take several years. In response, the industry has taken to recycling failed and existing medications for novel indications.
As specialty drugs continue to leave a mark on the health care space, take a look at specialty medications previously approved by the FDA that received new indications in 2017, thus far.
Graphic by Gwen Salas
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
TrumpRx Launches, Offering Cash-Paying Patients Discounted Drugs
2
SGLT2 Inhibitors in T2D Lower 5-Year Risk of CKD and Acute Kidney Injury
3
Pharmacist Takeover: CAR T Therapy Signals a Shift in ALL Treatment
4
Q&A: How Pharmacists Can Address Structural Barriers in Obesity Care
5


























